LncRNA HOXC-AS3 Accelerates Malignant Proliferation of Cervical Cancer Cells Via Stabilizing KDM5B

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 2024 Jun 6

PMID 38842683

Authors

Jie Li

Fang Hou

Zhenghua Teng

Weiwei Xia

Jie Peng

Affiliations

Soon will be listed here.

Abstract

Background: Cervical cancer (CC) is a common malignancy amongst women globally. Ubiquitination plays a dual role in the occurrence and development of cancers. This study analyzed the mechanism of long noncoding RNA HOXC cluster antisense RNA 3 (lncRNA HOXC-AS3) in malignant proliferation of CC cells via mediating ubiquitination of lysine demethylase 5B (KDM5B/JARID1B).

Methods: The expression patterns of lncRNA HOXC-AS3 and KDM5B were measured by real-time quantitative polymerase chain reaction or Western blot analysis. After transfection with lncRNA HOXC-AS3 siRNA and pcDNA3.1-KDM5B, proliferation of CC cells was assessed by the cell counting kit-8, colony formation, and 5-Ethynyl-2'-deoxyuridine staining assays. The xenograft tumor model was established to confirm the impact of lncRNA HOXC-AS3 on CC cell proliferation in vivo by measuring tumor size and weight and the immunohistochemistry assay. The subcellular location of lncRNA HOXC-AS3 and the binding of lncRNA HOXC-AS3 to KDM5B were analyzed. After treatment of lncRNA HOXC-AS3 siRNA or MG132, the protein and ubiquitination levels of KDM5B were determined. Thereafter, the interaction and the subcellular co-location of tripartite motif-containing 37 (TRIM37) and KDM5B were analyzed by the co-immunoprecipitation and immunofluorescence assays.

Results: LncRNA HOXC-AS3 and KDM5B were upregulated in CC tissues and cells. Depletion of lncRNA HOXC-AS3 repressed CC cell proliferation and in vivo tumor growth. Mechanically, lncRNA HOXC-AS3 located in the nucleus directly bound to KDM5B, inhibited TRIM37-mediated ubiquitination of KDM5B, and upregulated the protein levels of KDM5B. KDM5B overexpression attenuated the inhibitory role of silencing lncRNA HOXC-AS3 in CC cell proliferation in vivo and in vitro.

Conclusion: Nucleus-located lncRNA HOXC-AS3 facilitated malignant proliferation of CC cells via stabilization of KDM5B protein levels.

References

Li Y, Xie P, Lu L, Wang J, Diao L, Liu Z . An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network. Nat Commun. 2017; 8(1):347. PMC: 5570908. DOI: 10.1038/s41467-017-00299-9. View

Zhang Z, Zhang H, Sun H, Liu H, Liu M, Zhou Z . KDM5B promotes breast cancer cell proliferation and migration via AMPK-mediated lipid metabolism reprogramming. Exp Cell Res. 2019; 379(2):182-190. DOI: 10.1016/j.yexcr.2019.04.006. View

Zhao R, Song J, Jin Y, Liu Y . Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway. J Mol Histol. 2021; 52(5):991-1006. DOI: 10.1007/s10735-021-10007-z. View

Gong J, Yan S, Yu H, Zhang W, Zhang D . Increased Expression of Lysine-Specific Demethylase 5B (KDM5B) Promotes Tumor Cell Growth in Hep3B Cells and is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma. Med Sci Monit. 2018; 24:7586-7594. PMC: 6210936. DOI: 10.12659/MSM.910844. View

Bueno M, Richard S . SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase. Epigenetics. 2013; 8(11):1162-75. DOI: 10.4161/epi.26112. View

Xhabija B, Kidder B . KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer. Semin Cancer Biol. 2018; 57:79-85. PMC: 6522339. DOI: 10.1016/j.semcancer.2018.11.001. View

Song T, Xu A, Chen X, Gao J, Gao F, Kong X . Circular RNA circRNA_101996 promoted cervical cancer development by regulating miR-1236-3p/TRIM37 axis. Kaohsiung J Med Sci. 2021; 37(7):547-561. DOI: 10.1002/kjm2.12378. View

Zhang E, He X, Zhang C, Su J, Lu X, Si X . A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome Biol. 2018; 19(1):154. PMC: 6172843. DOI: 10.1186/s13059-018-1523-0. View

Su H, Fan G, Huang J, Qiu X . LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1. Cell Death Dis. 2022; 13(4):307. PMC: 8986809. DOI: 10.1038/s41419-022-04723-x. View

10.

Su J, Yu B, Zhang C, Yi P, Li H, Xu C . Long noncoding RNA HOXC-AS3 indicates a poor prognosis and regulates tumorigenesis by binding to YBX1 in breast cancer. Am J Transl Res. 2020; 12(10):6335-6350. PMC: 7653616. View

11.

Zhou B, Zhu Y, Xu W, Zhou Q, Tan L, Zhu L . Hypoxia Stimulates SUMOylation-Dependent Stabilization of KDM5B. Front Cell Dev Biol. 2022; 9:741736. PMC: 8719622. DOI: 10.3389/fcell.2021.741736. View

12.

Volkova L, Pashov A, Omelchuk N . Cervical Carcinoma: Oncobiology and Biomarkers. Int J Mol Sci. 2021; 22(22). PMC: 8624663. DOI: 10.3390/ijms222212571. View

13.

Chandrashekar D, Karthikeyan S, Korla P, Patel H, Shovon A, Athar M . UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022; 25:18-27. PMC: 8788199. DOI: 10.1016/j.neo.2022.01.001. View

14.

Galvao M, Coimbra E . Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: New molecular targets, current prospects. Crit Rev Oncol Hematol. 2020; 156:103111. DOI: 10.1016/j.critrevonc.2020.103111. View

15.

Kang J, Tang Q, He J, Li L, Yang N, Yu S . RNAInter v4.0: RNA interactome repository with redefined confidence scoring system and improved accessibility. Nucleic Acids Res. 2021; 50(D1):D326-D332. PMC: 8728132. DOI: 10.1093/nar/gkab997. View

16.

Zhu W, Chen X, Guo X, Liu H, Ma R, Wang Y . Low Glucose-Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer. Cancer Res. 2022; 82(5):805-818. DOI: 10.1158/0008-5472.CAN-21-1179. View

17.

Adiga D, Eswaran S, Pandey D, Sharan K, Kabekkodu S . Molecular landscape of recurrent cervical cancer. Crit Rev Oncol Hematol. 2020; 157:103178. DOI: 10.1016/j.critrevonc.2020.103178. View

18.

Xie M, Ma T, Xue J, Ma H, Sun M, Zhang Z . The long intergenic non-protein coding RNA 707 promotes proliferation and metastasis of gastric cancer by interacting with mRNA stabilizing protein HuR. Cancer Lett. 2018; 443:67-79. DOI: 10.1016/j.canlet.2018.11.032. View

19.

Feng C, Mell L, Sharabi A, McHale M, Mayadev J . Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer. Semin Radiat Oncol. 2020; 30(4):273-280. DOI: 10.1016/j.semradonc.2020.05.003. View

20.

Miao C, Liang C, Li P, Liu B, Qin C, Yuan H . TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner. J Exp Clin Cancer Res. 2021; 40(1):195. PMC: 8204444. DOI: 10.1186/s13046-021-01980-0. View